Terray Therapeutics uses AI and high-tech labs for rapid drug discovery, generating 50 terabytes of data daily. Co-founded by Jacob and Eli Berlin, the company focuses on small-molecule drugs. Their AI model accelerates development, with partnerships including Bristol Myers Squibb. Aiming to improve clinical success rates, Terray expects to begin trials by 2026.
Terray Therapeutics uses AI and high-tech labs for rapid drug discovery, generating 50 terabytes of data daily. Co-founded by Jacob and Eli Berlin, the company focuses on small-molecule drugs. Their AI model accelerates development, with partnerships including Bristol Myers Squibb. Aiming to improve clinical success rates, Terray expects to begin trials by 2026.